2-86507546-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016079.4(CHMP3):c.456C>A(p.Asp152Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000187 in 1,614,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016079.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHMP3 | NM_016079.4 | c.456C>A | p.Asp152Glu | missense_variant | 5/6 | ENST00000263856.9 | NP_057163.1 | |
RNF103-CHMP3 | NM_001198954.1 | c.543C>A | p.Asp181Glu | missense_variant | 7/8 | NP_001185883.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHMP3 | ENST00000263856.9 | c.456C>A | p.Asp152Glu | missense_variant | 5/6 | 1 | NM_016079.4 | ENSP00000263856 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251442Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135892
GnomAD4 exome AF: 0.000199 AC: 291AN: 1461850Hom.: 0 Cov.: 30 AF XY: 0.000187 AC XY: 136AN XY: 727216
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.456C>A (p.D152E) alteration is located in exon 5 (coding exon 5) of the CHMP3 gene. This alteration results from a C to A substitution at nucleotide position 456, causing the aspartic acid (D) at amino acid position 152 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at